Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

The interaction between cognition and motor control: A theoretical framework for dual-task interference effects on posture, gait initiation, gait and turning.

Bayot M, Dujardin K, Tard C, Defebvre L, Bonnet CT, Allart E, Delval A.

Neurophysiol Clin. 2018 Dec;48(6):361-375. doi: 10.1016/j.neucli.2018.10.003. Epub 2018 Oct 26. Review.

PMID:
30487064
2.

Electroencephalography-based machine learning for cognitive profiling in Parkinson's disease: Preliminary results.

Betrouni N, Delval A, Chaton L, Defebvre L, Duits A, Moonen A, Leentjens AFG, Dujardin K.

Mov Disord. 2018 Oct 21. doi: 10.1002/mds.27528. [Epub ahead of print]

PMID:
30345602
3.

Motor Preparation of Step Initiation: Error-related Cortical Oscillations.

Delval A, Braquet A, Dirhoussi N, Bayot M, Derambure P, Defebvre L, Tard C, Dujardin K.

Neuroscience. 2018 Nov 21;393:12-23. doi: 10.1016/j.neuroscience.2018.09.046. Epub 2018 Oct 10.

PMID:
30312784
4.

Dyspnea: An underestimated symptom in Parkinson's disease.

Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D, Defebvre L, Moreau C.

Parkinsonism Relat Disord. 2018 Sep 8. pii: S1353-8020(18)30386-9. doi: 10.1016/j.parkreldis.2018.09.001. [Epub ahead of print]

PMID:
30224267
5.

Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group.

Robert P, Lanctôt KL, Agüera-Ortiz L, Aalten P, Bremond F, Defrancesco M, Hanon C, David R, Dubois B, Dujardin K, Husain M, König A, Levy R, Mantua V, Meulien D, Miller D, Moebius HJ, Rasmussen J, Robert G, Ruthirakuhan M, Stella F, Yesavage J, Zeghari R, Manera V.

Eur Psychiatry. 2018 Oct;54:71-76. doi: 10.1016/j.eurpsy.2018.07.008. Epub 2018 Aug 17.

6.

Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity.

Mulders AEP, Moonen AJH, Dujardin K, Kuijf ML, Duits A, Flinois B, Handels RLH, Lopes R, Leentjens AFG.

J Psychosom Res. 2018 Sep;112:32-39. doi: 10.1016/j.jpsychores.2018.04.002. Epub 2018 Apr 10.

PMID:
30097133
7.

A quality project for radiation reduction in the cath lab.

de Ceuninck M, Muyldermans P, van de Walle S, Bergez B, Haspeslagh R, Stammen F, Dujardin K.

Acta Cardiol. 2019 Feb;74(1):38-44. doi: 10.1080/00015385.2018.1439705. Epub 2018 Feb 19.

PMID:
29457955
8.

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.

Huin V, Strubi-Vuillaume I, Dujardin K, Brion M, Delliaux M, Dellacherie D, Cuvellier JC, Cuisset JM, Riquet A, Moreau C, Defebvre L, Sablonnière B, Devos D.

Parkinsonism Relat Disord. 2017 Dec;45:85-89. doi: 10.1016/j.parkreldis.2017.09.014. Epub 2017 Sep 19.

PMID:
28947073
9.

Neurobiological correlates of emotional processing in Parkinson's disease: A systematic review of experimental studies.

Moonen AJH, Wijers A, Dujardin K, Leentjens AFG.

J Psychosom Res. 2017 Sep;100:65-76. doi: 10.1016/j.jpsychores.2017.07.009. Epub 2017 Jul 18. Review.

PMID:
28789795
10.

Left ventricular hypertrophy and papillary fibroelastoma in a patient with a MYBPC3 gene mutation.

Muyldermans P, de Ceuninck M, Dujardin K.

Acta Cardiol. 2017 Feb;72(1):75-76. doi: 10.1080/00015385.2017.1281550. No abstract available.

PMID:
28597742
11.

Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease.

Hassan M, Chaton L, Benquet P, Delval A, Leroy C, Plomhause L, Moonen AJ, Duits AA, Leentjens AF, van Kranen-Mastenbroek V, Defebvre L, Derambure P, Wendling F, Dujardin K.

Neuroimage Clin. 2017 Mar 6;14:591-601. doi: 10.1016/j.nicl.2017.03.002. eCollection 2017.

12.

Cognitive phenotypes in parkinson's disease differ in terms of brain-network organization and connectivity.

Lopes R, Delmaire C, Defebvre L, Moonen AJ, Duits AA, Hofman P, Leentjens AF, Dujardin K.

Hum Brain Mapp. 2017 Mar;38(3):1604-1621. doi: 10.1002/hbm.23474. Epub 2016 Nov 17.

PMID:
27859960
13.

Hallucinations and conscious access to visual inputs in Parkinson's disease.

Lefebvre S, Baille G, Jardri R, Plomhause L, Szaffarczyk S, Defebvre L, Thomas P, Delmaire C, Pins D, Dujardin K.

Sci Rep. 2016 Nov 14;6:36284. doi: 10.1038/srep36284.

14.

Attention modulation during motor preparation in Parkinsonian freezers: A time-frequency EEG study.

Tard C, Dujardin K, Bourriez JL, Molaee-Ardekani B, Derambure P, Defebvre L, Delval A.

Clin Neurophysiol. 2016 Dec;127(12):3506-3515. doi: 10.1016/j.clinph.2016.09.014. Epub 2016 Oct 5.

PMID:
27815974
15.

Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?

Moreau C, Devos D, Baille G, Delval A, Tard C, Perez T, Danel-Buhl N, Seguy D, Labreuche J, Duhamel A, Delliaux M, Dujardin K, Defebvre L.

PLoS One. 2016 Sep 21;11(9):e0162904. doi: 10.1371/journal.pone.0162904. eCollection 2016.

16.

Freezing/festination during motor tasks in early-stage Parkinson's disease: A prospective study.

Delval A, Rambour M, Tard C, Dujardin K, Devos D, Bleuse S, Defebvre L, Moreau C.

Mov Disord. 2016 Dec;31(12):1837-1845. doi: 10.1002/mds.26762. Epub 2016 Sep 13.

PMID:
27618808
17.

Effects of Stimulus-Driven and Goal-Directed Attention on Prepulse Inhibition of Brain Oscillations.

Annic A, Bourriez JL, Delval A, Bocquillon P, Trubert C, Derambure P, Dujardin K.

Front Hum Neurosci. 2016 Jul 29;10:390. doi: 10.3389/fnhum.2016.00390. eCollection 2016.

18.

Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.

Carriere N, Bourriez JL, Delval A, Derambure P, Defebvre L, Dujardin K.

J Parkinsons Dis. 2016 Jun 28;6(3):651-66. doi: 10.3233/JPD-160828.

PMID:
27372215
19.

French consensus procedure for assessing cognitive function in Parkinson's disease.

Dujardin K, Auzou N, Lhommée E, Czernecki V, Dubois B, Fradet A, Maltete D, Meyer M, Pineau F, Schmitt E, Sellal F, Tison F, Vidal T, Azulay JP, Welter ML, Corvol JC, Durif F, Rascol O; NS-Park network.

Rev Neurol (Paris). 2016 Nov;172(11):696-702. doi: 10.1016/j.neurol.2016.05.001. Epub 2016 Jun 16.

PMID:
27318613
20.

Ventilatory Dysfunction in Parkinson's Disease.

Baille G, De Jesus AM, Perez T, Devos D, Dujardin K, Charley CM, Defebvre L, Moreau C.

J Parkinsons Dis. 2016 Jun 16;6(3):463-71. doi: 10.3233/JPD-160804. Review.

21.

[Hallucinations and Parkinson's disease in the elderly: Pitfalls and medical care].

Leroy A, Roche J, Dujardin K, Duthoit D, Puisieux F, Pins D, Jardri R, Boulanger E.

Presse Med. 2016 May;45(5):522-31. doi: 10.1016/j.lpm.2015.12.013. Epub 2016 Mar 31. French.

PMID:
27039336
22.

Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson's disease.

Rieu I, Houeto JL, Pereira B, De Chazeron I, Bichon A, Chéreau I, Ulla M, Brefel-Courbon C, Ory-Magne F, Dujardin K, Tison F, Krack P, Durif F.

J Parkinsons Dis. 2016;6(1):267-77. doi: 10.3233/JPD-150747.

PMID:
27003781
23.

Non-compaction cardiomyopathy: a genetically and clinically heterogeneous disorder.

Rooms I, Dujardin K, De Sutter J.

Acta Cardiol. 2015 Dec;70(6):625-31. doi: 10.2143/AC.70.6.3120173. Review.

PMID:
26717209
24.

A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers.

Leroy C, Bourriez JL, Dujardin K, Molaee-Ardekani B, Babiloni C, Deplanque D, Ponchel A, Hennion S, Plomhause L, Devanne H, Deguil J, Payoux P, Blin O, Méligne D, Micallef J, Chauveau N, Lanteaume L, Vervueren C, Guimont F, Thalamas C, Cassé-Perrot C, Rouby F, Bordet R, Derambure P; PharmaCog Consortium.

Clin Neurophysiol. 2015 Nov 27. pii: S1388-2457(15)01119-0. doi: 10.1016/j.clinph.2015.11.018. [Epub ahead of print]

PMID:
26699666
25.

Modeling anxiety in Parkinson's disease.

Broen MP, Köhler S, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF.

Mov Disord. 2016 Mar;31(3):310-6. doi: 10.1002/mds.26461. Epub 2015 Dec 21.

PMID:
26685935
26.

Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.

Tard C, Demailly F, Delval A, Semah F, Defebvre L, Dujardin K, Moreau C.

J Parkinsons Dis. 2015;5(3):569-74. doi: 10.3233/JPD-150583.

PMID:
26406137
27.

How does visuospatial attention modulate motor preparation during gait initiation?

Tard C, Dujardin K, Girard A, Debaughrien M, Derambure P, Defebvre L, Delval A.

Exp Brain Res. 2016 Jan;234(1):39-50. doi: 10.1007/s00221-015-4436-0. Epub 2015 Sep 10.

PMID:
26358126
28.

Cognitive disorders in Parkinson's disease: Confirmation of a spectrum of severity.

Dujardin K, Moonen AJ, Behal H, Defebvre L, Duhamel A, Duits AA, Plomhause L, Tard C, Leentjens AF.

Parkinsonism Relat Disord. 2015 Nov;21(11):1299-305. doi: 10.1016/j.parkreldis.2015.08.032. Epub 2015 Aug 29.

PMID:
26350121
29.

Brain metabolic abnormalities during gait with freezing in Parkinson's disease.

Tard C, Delval A, Devos D, Lopes R, Lenfant P, Dujardin K, Hossein-Foucher C, Semah F, Duhamel A, Defebvre L, Le Jeune F, Moreau C.

Neuroscience. 2015 Oct 29;307:281-301. doi: 10.1016/j.neuroscience.2015.08.063. Epub 2015 Sep 1.

30.

Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia.

Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG.

Parkinsonism Relat Disord. 2015 Oct;21(10):1273-7. doi: 10.1016/j.parkreldis.2015.08.013. Epub 2015 Aug 14.

PMID:
26305998
31.

Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study.

Bocquillon P, Bourriez JL, Palmero-Soler E, Defebvre L, Derambure P, Dujardin K.

PLoS One. 2015 Jul 2;10(7):e0131654. doi: 10.1371/journal.pone.0131654. eCollection 2015.

32.

Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease.

Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K.

Neurology. 2015 May 26;84(21):2116-23. doi: 10.1212/WNL.0000000000001619. Epub 2015 Apr 29.

PMID:
25925985
33.

Specific Attentional Disorders and Freezing of Gait in Parkinson's Disease.

Tard C, Delval A, Duhamel A, Moreau C, Devos D, Dujardin K.

J Parkinsons Dis. 2015;5(2):379-87. doi: 10.3233/JPD-140498.

PMID:
25882060
34.

International validation of a behavioral scale in Parkinson's disease without dementia.

Rieu I, Martinez-Martin P, Pereira B, De Chazeron I, Verhagen Metman L, Jahanshahi M, Ardouin C, Chéreau I, Brefel-Courbon C, Ory-Magne F, Klinger H, Peyrol F, Schupbach M, Dujardin K, Tison F, Houeto JL, Krack P, Durif F.

Mov Disord. 2015 Apr 15;30(5):705-13. doi: 10.1002/mds.26223. Epub 2015 Mar 21.

PMID:
25809278
35.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

36.

Is the Parkinson Anxiety Scale comparable across raters?

Forjaz MJ, Ayala A, Martinez-Martin P, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Leentjens AF.

Mov Disord. 2015 Apr;30(4):545-51. doi: 10.1002/mds.26111. Epub 2014 Dec 27.

PMID:
25546697
37.

Factor analysis of the Hamilton Depression Rating Scale in Parkinson's disease.

Broen MP, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF.

Parkinsonism Relat Disord. 2015 Feb;21(2):142-6. doi: 10.1016/j.parkreldis.2014.11.016. Epub 2014 Nov 29.

PMID:
25523963
38.

Gait and attentional performance in freezers under methylphenidate.

Delval A, Moreau C, Bleuse S, Guehl D, Bestaven E, Guillaud E, Dujardin K, Defebvre L, Devos D.

Gait Posture. 2015 Feb;41(2):384-8. doi: 10.1016/j.gaitpost.2014.10.022. Epub 2014 Oct 30.

PMID:
25468682
39.

Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms.

Dujardin K, Langlois C, Plomhause L, Carette AS, Delliaux M, Duhamel A, Defebvre L.

Mov Disord. 2014 Dec;29(14):1796-801. doi: 10.1002/mds.26058. Epub 2014 Nov 5.

PMID:
25370724
40.

Genetic characterization of cognitive impairment in Parkinson's disease.

Dujardin K, Devos D.

Brain. 2014 Oct;137(Pt 10):2630-1. doi: 10.1093/brain/awu218. No abstract available.

PMID:
25217791
41.

TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment.

Delplanque J, Devos D, Huin V, Genet A, Sand O, Moreau C, Goizet C, Charles P, Anheim M, Monin ML, Buée L, Destée A, Grolez G, Delmaire C, Dujardin K, Dellacherie D, Brice A, Stevanin G, Strubi-Vuillaume I, Dürr A, Sablonnière B.

Brain. 2014 Oct;137(Pt 10):2657-63. doi: 10.1093/brain/awu202. Epub 2014 Jul 28.

PMID:
25070513
42.

The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.

Leentjens AF, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Martinez-Martin P.

Mov Disord. 2014 Jul;29(8):1035-43. doi: 10.1002/mds.25919. Epub 2014 May 23.

PMID:
24862344
43.

Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.

Carriere N, Besson P, Dujardin K, Duhamel A, Defebvre L, Delmaire C, Devos D.

Mov Disord. 2014 Jun;29(7):897-903. doi: 10.1002/mds.25904. Epub 2014 May 10.

PMID:
24817690
44.

Predictive factors for improvement of gait by low-frequency stimulation in Parkinson's disease.

Annic A, Moreau C, Salleron J, Devos D, Delval A, Dujardin K, Touzet G, Blond S, Destée A, Defebvre L.

J Parkinsons Dis. 2014;4(3):413-20. doi: 10.3233/JPD-130337.

PMID:
24763085
45.

The spatiotemporal dynamics of early attention processes: a high-resolution electroencephalographic study of N2 subcomponent sources.

Bocquillon P, Bourriez JL, Palmero-Soler E, Molaee-Ardekani B, Derambure P, Dujardin K.

Neuroscience. 2014 Jun 20;271:9-22. doi: 10.1016/j.neuroscience.2014.04.014. Epub 2014 Apr 18.

PMID:
24747215
46.

[Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].

Rambour M, Moreau C, Salleron J, Devos D, Kreisler A, Mutez E, Simonin C, Annic A, Dujardin K, Destée A, Defebvre L.

Rev Neurol (Paris). 2014 Mar;170(3):205-15. doi: 10.1016/j.neurol.2013.10.012. Epub 2014 Mar 1. French.

PMID:
24594365
47.

Effects of stimulus-driven and goal-directed attention on prepulse inhibition of the cortical responses to an auditory pulse.

Annic A, Bocquillon P, Bourriez JL, Derambure P, Dujardin K.

Clin Neurophysiol. 2014 Aug;125(8):1576-88. doi: 10.1016/j.clinph.2013.12.002. Epub 2013 Dec 17.

PMID:
24411526
48.

Attention modulates step initiation postural adjustments in Parkinson freezers.

Tard C, Dujardin K, Bourriez JL, Destée A, Derambure P, Defebvre L, Delval A.

Parkinsonism Relat Disord. 2014 Mar;20(3):284-9. doi: 10.1016/j.parkreldis.2013.11.016. Epub 2013 Dec 25.

PMID:
24405757
49.

Apathy and impaired recognition of emotion: are they related in Parkinson's disease?

Dujardin K, Lopes R.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1061. doi: 10.1136/jnnp-2013-307224. Epub 2014 Jan 8. No abstract available.

PMID:
24403281
50.

Brugada syndrome presenting as an acute coronary syndrome.

Buysschaert I, De Rybel R, Dujardin K.

Acta Cardiol. 2013 Oct;68(5):521-3.

PMID:
24283116

Supplemental Content

Loading ...
Support Center